{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-085977","form_type":"8-K","ticker":"VYGR","cik":"0001640266","company_name":"Voyager Therapeutics, Inc.","filed_at":"2025-09-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.542360+00:00","generated_at":"2026-05-17T08:52:00.310744+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"Voyager Therapeutics presents at Citi Biopharma Conference; no specific updates disclosed in filing excerpt","bullets":["Company presented at Citi's 2025 Biopharma Back to School Conference on September 2, 2025.","Presentation titled 'Leveraging Genetics to Treat Neurological Diseases' focuses on genetic approaches.","No financial results, pipeline milestones, or guidance changes are identifiable from the provided excerpt.","The filing does not contain material new information beyond the fact of the presentation."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-085977","json":"https://secwatch.observer/filing/0001104659-25-085977.json","markdown":"https://secwatch.observer/filing/0001104659-25-085977.md","text":"https://secwatch.observer/filing/0001104659-25-085977.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925085977/0001104659-25-085977-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925085977/tm2524800d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:52:00.310744+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}